Overall group (n=76) | Responsive patients (n=52) | Non-responsive patients (n=24) | P-value | |
---|---|---|---|---|
Male | 53 (69.7%) | 36 (69.2%) | 17 (70.8%) | 0.888 |
Age at onset, years (mean±SD) | 8.51±6.92 | 9.53±7.61 | 6.25±4.46 | 0.052 |
Age at surgery, years (mean±SD) | 21.40±9.09 | 22.21±9.71 | 19.63±7.46 | 0.252 |
Mean epilepsy duration, years (mean±SD) | 13.12±7.86 | 13.00±8.55 | 13.38±6.24 | 0.831 |
Pre-operative seizure frequency/month (range) | 13 (5-60) | 11 (5-62) | 37 (5-60) | 0.580 |
Predominant seizure type | ||||
GTCS | 12 (15.8%) | 9 (17.3%) | 3 (12.5%) | |
Atypical absence | 12 (15.8%) | 5 (9.6%) | 7 (29.2%) | |
Spasm | 10 (13.2%) | 6 (11.5%) | 4 (16.7%) | |
Tonic seizure | 2 (2.6%) | 2 (3.8%) | 0 | 0.026 |
Myoclonic seizure | 5 (6.6%) | 4 (7.7%) | 1 (4.2%) | |
Partial seizure | 33 (43.4%) | 25 (48.1%) | 8 (33.3%) | |
Others | 2 (2.6%) | 1 (1.9%) | 1 (4.2%) | |
MRI lesions | 0.639 | |||
Positive | 35 (46.1%) | 23 (44.2%) | 12 (50.0%) | |
Negative | 41 (53.9%) | 29 (38.2%) | 12 (50.0%) | |
History of surgical treatment | 0.531 | |||
Yes | 23 (30.3%) | 14 (26.9%) | 9 (37.5%) | |
No | 53 (69.7%) | 38 (73.1%) | 15 (62.5%) |